ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 300

Patient-Reported Joint Count in Juvenile Idiopathic Arthritis: The Reliability of a Mannequin Format

Maryanne Dijkstra1, Janneke Anink1, Philomine A. van Pelt1,2, Johanna M.W. Hazes2 and Lisette W.A. van Suijlekom-Smit1, 1Pediatric Rheumatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands, 2Rheumatology, Erasmus MC, Rotterdam, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Adolescent patients, juvenile idiopathic arthritis (JIA) and patient outcomes

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Juvenile idiopathic arthritis (JIA) is a common chronic disease, requiring regular monitoring. Patient-reported outcomes can assist monitoring, may promote patient self-management and can be useful in epidemiological surveys. Our objective was to evaluate reliability of a mannequin-format patient-reported joint-count in JIA, and to detect changes in agreement at a follow-up visit.

Methods: JIA patients aged 12-21 marked joints with active arthritis on a mannequin (see Figure 1) before their regular clinic visit. The physician performed a joint-count without having seen the patient’s assessment. For two subsequent clinic visits, agreement between the physician and patient-reported joint-counts was assessed using Intraclass Correlation Coefficient (ICC) and kappa statistics. The ability of the patient-reported joint-count to discriminate between active and inactive disease was evaluated using positive and negative predictive values. Sensitivity to change was estimated using Pearsons’s rho and standardized response mean (SRM).

Results: 75 JIA patients were included. In general, patients had a low number of active joints (median 1 joint, indicated by the physician). ICC was moderate (0.61) and kappas ranged from 0.3-0.7. At the follow-up (n= 53), kappas were similar; the ICC was 0.19. When a patient scored 0 joints, the physician confirmed this in 93-100%. When the patient marked ≥ 1 joints, the physician confirmed arthritis in 59-76%. Sensitivity to change was moderate (Pearson’s rho: 0.44, p=0.001, SRM in worsening patients: 0.67).

Conclusion: Agreement between physician and patient on joint-counts was reasonable. Untrained patients tended to overestimate presence of arthritis when they marked active joints on a mannequin-format joint-count. When the patient indicated absence of arthritis, the physician usually confirmed this. The sensitivity to change was moderate for patients who worsened over time.The agreement did not improve at follow-up; future research should focus on the possibility of achieving this through training. For now, the patient-reported joint-count cannot fully replace the physicians’ joint-count in clinical practice; it may be used in epidemiological studies with caution.

Figure 1 Mannequin (translated from Dutch)


Disclosure:

M. Dijkstra,
None;

J. Anink,
None;

P. A. van Pelt,
None;

J. M. W. Hazes,
None;

L. W. A. van Suijlekom-Smit,

Pfizer Inc,

2.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-joint-count-in-juvenile-idiopathic-arthritis-the-reliability-of-a-mannequin-format/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology